Genetic alterations in peritoneal metastatic tumors predicted the outcomes for hyperthermic intraperitoneal chemotherapy.

Front Oncol · 2023 · PMC10170308 · PMID 37182141

Europe PMC DOI

hedged sentence

0.4316

closest p · 8.6× alpha

0.4316

boldest claim

The sentences

did not reach statistical significancep = 0.4316not close (p > 0.1)

Results revealed higher TMB in pretreatment tumors of non-responders; however, the difference did not reach statistical significance (median TMB of 133.04 mutations/Mb vs. 71.14 mutations/Mb, p = 0.4316) ( Figure S1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.